No Record Found
Sector
PharmaceuticalsOpen
₹6,182.5Prev. Close
₹6,182.5Turnover(Lac.)
₹617.66Day's High
₹6,374Day's Low
₹6,182.552 Week's High
₹6,50052 Week's Low
₹4,863Book Value
₹363.35Face Value
₹10Mkt Cap (₹ Cr.)
10,449.31P/E
34.72EPS
181.09Divi. Yield
1.99No Record Found
Y/e 31 Mar( In .Cr) | Mar-2025 | Jun-2024 | Jun-2023 | Jun-2022 |
---|---|---|---|---|
Equity Capital | 16.6 | 16.6 | 16.6 | 16.6 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 520.36 | 521.64 | 734.29 | 599.89 |
Net Worth | 536.96 | 538.24 | 750.89 | 616.49 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Jun-2021 | Jun-2020 | Dec-2017 | Dec-2016 |
---|---|---|---|---|
Revenue | 1,008.73 | 1,355.86 | 1,103.96 | 992.56 |
yoy growth (%) | -25.6 | 22.81 | 11.22 | 5.64 |
Raw materials | -314.82 | -431.44 | -441.09 | -411.54 |
As % of sales | 31.2 | 31.82 | 39.95 | 41.46 |
Employee costs | -150.47 | -182.93 | -169.64 | -154.23 |
Y/e 31 Mar( In .Cr) | Jun-2021 | Jun-2020 | Dec-2017 | Dec-2016 |
---|---|---|---|---|
Profit before tax | 233.28 | 354.85 | 135.19 | 115.17 |
Depreciation | -30.04 | -29.45 | -26.4 | -24.81 |
Tax paid | -56.48 | -100.77 | -58.28 | -36.04 |
Working capital | -233.3 | 269.12 | 35.2 | 57.07 |
Other operating items |
Y/e 31 Mar | Jun-2021 | Jun-2020 | Dec-2017 | Dec-2016 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -25.6 | 22.81 | 11.22 | 5.64 |
Op profit growth | -21.99 | 129.18 | 19.07 | 38.5 |
EBIT growth | -34.03 | 162.48 | 17.38 | 38.2 |
Net profit growth | -30.41 | 170.55 | 18.67 | 47.74 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,641.4 | 79.12 | 3,94,114.76 | 753.53 | 0.97 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,132.5 | 69.66 | 1,62,734.89 | 557 | 0.49 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,564 | 24.45 | 1,26,312.54 | 1,303.13 | 1.02 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,623 | 61.66 | 1,22,586.2 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,260.4 | 15.25 | 1,05,094.71 | 2,961.2 | 0.63 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Milind Thatte
Non Executive Director
Aalok Agrawal
Chairperson
S Madhavan
Executive Director & Chief Financial Officer
Lokesh Chandak
Non Executive Director
Seema Sambasivan
Independent Director
Krishna Sarma
Independent Director
SHARAD TYAGI
Company Sec. & Compli. Officer
Zeal Rupani
Godrej One 8th Floor,
Projshanagar Vikhroli (East),
Maharashtra - 400079
Tel: 91-22-62109000
Website: http://www.pghealthindia.com
Email: investorgrievance.im@pg.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967. The Companys name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002. Later, the...
Read More
Reports by Procter & Gamble Health Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.